Cargando…
Protective Effect of Remdesivir Against Pulmonary Fibrosis in Mice
Pulmonary fibrosis is a known sequela of severe or persistent lung damage. Existing clinical, imaging and autopsy studies have shown that the lungs exhibit a pathological pulmonary fibrosis phenotype after infection with coronaviruses, including severe acute respiratory syndrome coronavirus 2 (SARS-...
Autores principales: | Li, Xiaohe, Liu, Rui, Cui, Yunyao, Liang, Jingjing, Bi, Zhun, Li, Shimeng, Miao, Yang, Zhang, Liang, Li, Xiaoping, Zhou, Honggang, Yang, Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427522/ https://www.ncbi.nlm.nih.gov/pubmed/34512328 http://dx.doi.org/10.3389/fphar.2021.692346 |
Ejemplares similares
-
Antifibrotic Mechanism of Cinobufagin in Bleomycin-Induced Pulmonary Fibrosis in Mice
por: Li, Xiaohe, et al.
Publicado: (2019) -
Ellagic Acid Attenuates BLM-Induced Pulmonary Fibrosis via Inhibiting Wnt Signaling Pathway
por: Li, Xiaohe, et al.
Publicado: (2021) -
Antifibrotic mechanism of avitinib in bleomycin-induced pulmonary fibrosis in mice
por: Miao, Yang, et al.
Publicado: (2023) -
Protective Effect of Arbidol Against Pulmonary Fibrosis and Sepsis in Mice
por: Li, Hailong, et al.
Publicado: (2021) -
Baricitinib Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice by Inhibiting TGF-β1 Signaling Pathway
por: Gu, Songtao, et al.
Publicado: (2023)